These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 9892187

  • 1. Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients.
    Esteller M, Sanchez-Cespedes M, Rosell R, Sidransky D, Baylin SB, Herman JG.
    Cancer Res; 1999 Jan 01; 59(1):67-70. PubMed ID: 9892187
    [Abstract] [Full Text] [Related]

  • 2. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.
    Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, Tavecchio L, Daidone MG, Sozzi G.
    Clin Cancer Res; 2002 Dec 01; 8(12):3782-7. PubMed ID: 12473590
    [Abstract] [Full Text] [Related]

  • 3. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients.
    Rosas SL, Koch W, da Costa Carvalho MG, Wu L, Califano J, Westra W, Jen J, Sidransky D.
    Cancer Res; 2001 Feb 01; 61(3):939-42. PubMed ID: 11221887
    [Abstract] [Full Text] [Related]

  • 4. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
    Zöchbauer-Müller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD.
    Cancer Res; 2001 Jan 01; 61(1):249-55. PubMed ID: 11196170
    [Abstract] [Full Text] [Related]

  • 5. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S, Fujimoto N, Hiraki A, Gemba K, Takigawa N, Fujiwara K, Fujii M, Umemura H, Satoh M, Tabata M, Ueoka H, Kiura K, Kishimoto T, Tanimoto M.
    Carcinogenesis; 2008 Sep 01; 29(9):1845-9. PubMed ID: 18632757
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Can aberrant promoter hypermethylation of CpG islands predict the clinical outcome of non-small cell lung cancer after curative resection?
    Kim YT, Lee SH, Sung SW, Kim JH.
    Ann Thorac Surg; 2005 Apr 01; 79(4):1180-8; discussion 1180-8. PubMed ID: 15797047
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Gene promoter hypermethylation in tumors and lymph nodes of stage I lung cancer patients.
    Harden SV, Tokumaru Y, Westra WH, Goodman S, Ahrendt SA, Yang SC, Sidransky D.
    Clin Cancer Res; 2003 Apr 01; 9(4):1370-5. PubMed ID: 12684406
    [Abstract] [Full Text] [Related]

  • 12. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tumor-specific methylation in bronchial lavage for the early detection of non-small-cell lung cancer.
    Kim H, Kwon YM, Kim JS, Lee H, Park JH, Shim YM, Han J, Park J, Kim DH.
    J Clin Oncol; 2004 Jun 15; 22(12):2363-70. PubMed ID: 15197197
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer].
    Yu ZH, Wang YC, Chen LB, Song Y, Liu C, Xia XY, Lin Q, Ma CY.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 15; 30(4):284-7. PubMed ID: 18788633
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS, Chen TP, Hung CH, Wen CK, Lin RK, Lee HC, Wang YC.
    Cancer; 2007 Nov 01; 110(9):2019-26. PubMed ID: 17876837
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.